GENEVA, July 11 — Swiss regulators have approved the first-ever antimalarial drug specifically designed for newborns weighing less than 11 pounds, marking a breakthrough in efforts to treat the disease in the most vulnerable infants. Pharmaceutical giant Novartis developed the new formulation of artemether-lumefantrine, designed as a cherry-flavored, rapidly dissolving tablet that can be given […]
(ATLANTA, July 10, 2025) — The U.S. is facing its worst measles outbreak in over three decades, with cases surpassing 1,280 by mid-year and health officials linking the surge to declining MMR vaccine coverage. According to the Centers for Disease Control and Prevention (CDC), 1,288 confirmed measles cases have been reported so far this year, […]